BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20847603)

  • 1. [Pathophysiology of portal hypertension, what's new?].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2010 Sep; 56(3):129-34. PubMed ID: 20847603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic alterations in cirrhosis and portal hypertension.
    Kim MY; Baik SK; Lee SS
    Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of portal hypertension.
    Gupta TK; Chen L; Groszmann RJ
    Clin Liver Dis; 1997 May; 1(1):1-12. PubMed ID: 15562664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the pathophysiology of portal hypertension.
    Tsai YT; Lin HC; Lee SD
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S283-7. PubMed ID: 9407348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
    Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
    Iwakiri Y; Shah V; Rockey DC
    J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.
    Iwakiri Y
    Liver Int; 2012 Feb; 32(2):199-213. PubMed ID: 21745318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
    Thabut D; Shah V
    J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of portal hypertension].
    Montaño-Loza A; Meza-Junco J
    Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal hypertension secondary to myelofibrosis: a study of three cases.
    Alvarez-Larrán A; Abraldes JG; Cervantes F; Hernández-Guerra M; Vizzutti F; Miquel R; Gilabert R; Giusti M; Garcia-Pagan JC; Bosch J
    Am J Gastroenterol; 2005 Oct; 100(10):2355-8. PubMed ID: 16181389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes and pathomechanisms of oesophageal varices development.
    Paquet KJ
    Med Sci Monit; 2000; 6(5):915-28. PubMed ID: 11208432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vasoactive substances and cellular effectors in the pathophysiology of cirrhotic portal hypertension: the past, the present and the future--Georges Brohée Lecture.
    Laleman W
    Acta Gastroenterol Belg; 2009; 72(1):9-16. PubMed ID: 19402365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.